[Hereditary antithrombin deficiency and pregnancy--what is the effective thromboprophylaxis?].
Majak
Peter
P
Medisinsk klinikk Aker universitetssykehus 0514 Oslo. ulrich.abildgaard@ioks.uio.no
Vikskjold
Florin
F
Abildgaard
Ulrich
U
D000925:Anticoagulants / Q000008:administration & dosage; D000990:Antithrombin III / Q000008:administration & dosage; D020152:Antithrombin III Deficiency / Q000150:complications / Q000188:drug therapy / Q000235:genetics*; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006493:Heparin / Q000008:administration & dosage; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy / Q000517:prevention & control*; D011256:Pregnancy Outcome; D012189:Retrospective Studies; D012307:Risk Factors; D011795:Surveys and Questionnaires; D015912:Thrombolytic Therapy; D020246:Venous Thrombosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D000990:Antithrombin III; D006493:Heparin